Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

intervet ireland limited - pasteurella multocida erysipelothrix rhusiopathiae strain m2 (serotype 2) - suspension for injection - fowl - immunological

Umoja wa Ulaya - Kiingereza - EMA (European Medicines Agency)

laboratorios hipra s.a. - inactivated bordetella bronchiseptica, strain 833cer / recombinant type-d pasteurella-multocida toxin (pmtr) - immunologicals - pigs (gilts and sows) - for the passive protection of piglets via colostrum after active immunisation of sows and gilts to reduce the clinical signs and lesions of progressive and non-progressive atrophic rhinitis, as well as to reduce weight loss associated with bordetella-bronchiseptica and pasteurella-multocida infections during the fattening period. challenge studies have demonstrated that passive immunity lasts until piglets are six weeks of age while in clinical field trials, the beneficial effects of vaccination (reduction in nasal lesion score and weight loss) are observed until slaughter.

Australia - Kiingereza - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apvma permit - riemerella anatipestifer+pasteurella multocida - vaccine

Australia - Kiingereza - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - trimethoprim; sulfadiazine - oral tablet - trimethoprim pyrimidine active 80.0 mg/tb; sulfadiazine sulfanyl active 400.0 mg/tb - antibiotic & related - dog | bitch | castrate | puppy - bacterial infection | organisms sensitive to combination of | amoxycillin sensitive bacteria | associated with viral disease | gram negative organisms | gram positive organisms | post parturient bacterial infe | primary bacterial infection | sulfadiazine sensitive bacteri | trimethoprim sensitive bacteri | tylosin sensitive bacteria

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

zoetis ireland limited - pasteurella multocida strain x-73 (serovar 1), inactivated, pasteurella multocida strain p-1059 (serovar 3), inactivated, pasteurella multocida strain p-1662 (serovar 4), inactivated, pasteurella multocida, strain cu (serovar 3x4), inactivated - emulsion for injection - unknown - pasteurella vaccine - fowl - chicken, fowl - duck, fowl - turkey - immunological - inactivated vaccine

Nyuzilandi - Kiingereza - Ministry for Primary Industries

pacificvet limited - pasteurella multocida (inactivated) - pasteurella multocida (inactivated) 0 vaccine - vaccine

Marekani - Kiingereza - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - linezolid (unii: isq9i6j12j) (linezolid - unii:isq9i6j12j) - linezolid 600 mg - linezolid tablets are indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. linezolid tablets are not indicated for the treatment of gram-negative infections. it is critical that specific gram-negative therapy be initiated immediately if a concomitant gram-negative pathogen is documented or suspected [see warnings and precautions (5.4) ]. nosocomial pneumonia caused by staphylococcus aureus (methicillin-susceptible and -resistant isolates) or streptococcus pneumoniae [see clinical studies (14) ]. community-acquired pneumonia caused by streptococcus pneumoniae , including cases with concurrent bacteremia, or staphylococcus aureus (methicillin-susceptible isolates only) [see clinical studies (14) ]. complicated skin and skin structure infections, including diabetic foot infections, without concomitant osteomyelitis , caused by staphylococcus aureus (methicillin-susceptible and -resistant isolates), streptococcus py

Ubelgiji - Kiingereza - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

boehringer ingelheim animal health belgium - pasteurella multocida; pasteurella multocida anatoxine; bordetella bronchiseptica - suspension for injection - pasteurella multocida; pasteurella multocida anatoxine; bordetella bronchiseptica - bordetella + pasteurella - pig

Filipino - Kiingereza - FDA (Food And Drug Administration)

elanco philippines, inc.; distributor: elanco philippines, inc. - inactivated actinobacillus pleuropneumoniae , glaesserella parasuis , pasteurella multocida bacterin - solution for injection (im) - ormulation: each 2 ml contains: actinobacillus pleuropneumoniae, strain 80-1144 - gli (serotype 1) 21.27 od (600 nm) actinobacillus pleuropneumoniae, strain 81-1319 - gl4 (serotype 5) >i.26 od (600 nm) actinobacillus pleuropneumoniae, strain 5751-7 - gl34 (serotype 7) >i.37 od (600 nm) glaesserella parasuis >i.53 od (600 nm) pasteurella multocida serotype a, strain 169 26.3 x 10°cfu (0.28 ml)

Filipino - Kiingereza - FDA (Food And Drug Administration)

hipra philippines, inc.; distributor: hipra philippines, inc. - inactivated pasteurella multocida , actinobacillus pleuropneumoniae vaccine (vet.) - suspension for injection (im) - formulation: each 2 ml (dose) contains: pasteurella multocida (type a)... ............ 8 x 10^9 actinobacillus pleuropneumoniae (serotype 2) ............ >1/4 mat titer actinobacillus pleuropneumoniae (serotype 4)............. >1/4 mat titer actinobacillus pleuropneumoniae (serotype 5) ............. > 1/4 mat titer mat - microagglutination test